Ledger.Open graph →
SEC Form D · filed August 17, 2021

NERVGEN PHARMA CORP

Offering
$442K
Sold
$264K
Exemption
Rule 506(b)
Industry
Other
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Randall Kaye · Vancouver, British Columbia, CanadaDirectorWilliam Adams · Vancouver, British Columbia, CanadaExecBrian J. Bayley · Vancouver, British Columbia, CanadaDirectorDaniel Mikol · Vancouver, British Columbia, CanadaExecPaul Brennan · Vancouver, British Columbia, CanadaExec · DirectorHarold J. Punnett · Vancouver, British Columbia, CanadaDirectorMichael Abrams · Vanouver, British Columbia, CanadaDirectorBill Radvak · Vancouver, British Columbia, CanadaDirectorRoger Tichenor · Sarasota, FLDirectorJacob L. Block · Grove City, OHExecZarrell R. Gray · Zionsville, INDirectorBesar N. Muhameti · Luxembourg, LuxembourgDirectorRichard R. Halderman · Zionsville, INDirectorJane N. Wilkinson · Luxembourg, LuxembourgExecBruce Cassidy · Sarasota, FLDirectorRod W. Saddington · DALLAS, TXExec · DirectorAndrew Hemingway · Bristol, NHDirectorMLG Fund Manager LLC · Brookfield, WIDirectorYuriy Gordiyenko · Brooklyn, NYDirectorMikhail Zlotnik · Brooklyn, NYDirectorYuriy Novodvorskiy · Brooklyn, NYExec · DirectorAlina Trigub · Brooklyn, NYExecDaniel A. Gold · New York, NYDirectorBrent E. Carey · Long Beach, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗